Drug Co. Ex-CEO Liable For $1M FBAR Penalty

By David Hansen · December 4, 2020, 8:05 PM EST

A pharmaceutical company's former CEO faces a $1 million penalty for failing to disclose a foreign bank account after a federal court decided Friday he recklessly disregarded his duty to file....

To view the full article, register now.

Documents

Case Information

Case Title

BEDROSIAN v. THE UNITED STATES OF AMERICA, DEPARTMENT OF THE TREASURY, INTERNAL REVENUE SERVICE

Case Number

2:15-cv-05853

Court

Pennsylvania Eastern

Nature of Suit

Tax Suits: Taxes

Date Filed

October 27, 2015